Matthew During
Geen lopende functies
Profiel
Matthew During is the founder of Merlin Pharma Pvt Ltd.
(1993), NightstaRx Ltd.
(2014), Nightstar Therapeutics Ltd.
(2014), and Ovid Therapeutics, Inc. (2014).
At Ovid Therapeutics, Inc., he held the titles of President, Director & Chief Scientific Officer from 2015 to 2019.
Dr. During's former jobs include Senior Manager at Bridgewater Associates LP (2014), Professor-Neurosurgery at Yale University (1989-2000), Professor at Cornell University, and Professor at The Ohio State University (2006-2014).
Dr. During received his undergraduate and doctorate degrees from Auckland University.
Dr. During is also the founder of Neurologix, Inc...
Eerdere bekende functies van Matthew During
| Bedrijven | Functie | Einde |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Executive Officer | 01-03-2015 |
Bridgewater Associates LP
 Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Corporate Officer/Principal | 01-12-2014 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01-12-2014 |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | 01-01-2006 |
| Yale University | Corporate Officer/Principal | 01-01-2000 |
Opleiding van Matthew During
| Auckland University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Bridgewater Associates LP
Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Finance |
| Neurologix, Inc. /Old/ | Commercial Services |
| Merlin Pharma Pvt Ltd. | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
